Loading company…
Ocera Therapeutics develops biopharmaceutical treatments for chronic conditions.
Based in San Diego, US, Ocera Therapeutics develops biopharmaceutical treatments for chronic conditions. It became a public company through a merger with a Tranzyme subsidiary in April 2013. The company raised USD 28.00 mn, including USD 20.00 mn in venture debt on March 24, 2013, from investors including Oxford Financial Corporation and Silicon Valley Bank.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in